Drug intelligence / Profile preview

coenzyme Q10 + feverfew + magnesium

Development stage
Unknown
Lead developer
PiLeJe
Modality
Small Molecules
Administration
Oral
01

Overview

Antemig is a fixed-dose nutraceutical combination containing coenzyme Q10, feverfew (Tanacetum parthenium), and magnesium, developed by PiLeJe for the prophylaxis of migraine in adults. The supplement targets multiple pathophysiological pathways associated with migraines: feverfew contains parthenolide, which inhibits the release of serotonin and pro-inflammatory prostaglandins; coenzyme Q10 acts as an antioxidant and electron carrier to address mitochondrial dysfunction; and magnesium helps correct deficient energy metabolism and neuronal excitability. Clinical evidence suggests that daily supplementation significantly reduces the frequency of migraine attacks, with studies showing a reduction from 4.9 to 1.3 migraine days per month after three months of use.

Brand names
Antemig
Other names
coenzyme Q10 + feverfew + magnesium
02

Targets

ND1 (Mitochondrial electron transport chain complex I)COX-3 (Mitochondrially encoded cytochrome c oxidase subunit 3)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on coenzyme Q10 + feverfew + magnesium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coenzyme Q10 + feverfew + magnesium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call